Catalyst Wire Dossier Catalyst Wire Dossier

Emollient cream containing pre- and postbiotics and 4% niacinamide

· Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Emollient cream containing pre- and postbiotics and 4% niacinamide, covering 2025-03-11 to 2025-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFR [NA]

See pricing